domingo, 12 de octubre de 2014

Preventing Chronic Disease | Toward an Integrated Public Health Approach for Epilepsy in the 21st Century - CDC

full-text ►

Preventing Chronic Disease | Toward an Integrated Public Health Approach for Epilepsy in the 21st Century - CDC



Preventing Chronic Disease Logo



Toward an Integrated Public Health Approach for Epilepsy in the 21st Century

Howard K. Koh, MD, MPH; Rosemarie Kobau, MPH; Vicky H. Whittemore, PhD; Marie Y. Mann, MD, MPH; Jennifer G. Johnson, EdD; Joseph D. Hutter, MD; Wanda K. Jones, DrPH

Suggested citation for this article: Koh HK, Kobau R, Whittemore VH, Mann MY, Johnson JG, Hutter JD, et al. Toward an Integrated Public Health Approach for Epilepsy in the 21st Century. Prev Chronic Dis 2014;11:140270. DOI: http://dx.doi.org/10.5888/pcd11.140270External Web Site Icon.
PEER REVIEWED

Abstract

Epilepsy, a complex spectrum of disorders, merits enhanced public health action. In 2012, the Institute of Medicine (IOM) released a seminal report on the public health dimensions of the epilepsies, recommending actions in 7 domains. The report urged a more integrated and coordinated national approach for care centering on the whole patient, including heightened attention to comorbidities and quality of life; more timely referral and access to treatments; and improved community resources, education, stakeholder collaboration, and public communication. The US Department of Health and Human Services responded to this report by accelerating and integrating ongoing initiatives and beginning new ones. This article summarizes recent federally supported activities promoting an integrated public health approach for epilepsy, highlighting progress in response to the landmark 2012 IOM report and identifying opportunities for continued public health action.

Introduction and Background

Despite being recognized for millennia, epilepsy is poorly understood by the public today. Epilepsy represents a complex spectrum of disorders that varies by type, cause, severity, and impact (1,2). Epilepsy can not only shorten life but also severely compromise overall well-being and full participation in life activities (1–3). Hence, epilepsy is not just a trying neurological disorder for individuals but also a broader public health challenge for society (1,4–7). This article summarizes federally supported activities promoting an integrated public health approach for epilepsy, highlighting recent progress in response to the landmark 2012 Institute of Medicine (IOM) report, Epilepsy Across the Spectrum: Promoting Health and Understanding (2).
Some national efforts previously spurred planning to address epilepsy in the United States. For example, in 1975, the Plan for Nationwide Action on Epilepsy, commissioned by Congress and led by the former Department of Health, Education, and Welfare, identified the burden of epilepsy in the population and released a first set of groundbreaking recommendations to federal and state agencies (5). Later, 2 national conferences, Living Well with Epilepsy I (1997) and Living Well with Epilepsy II (2003), convened an expanded group of stakeholders to assess progress and gaps for continued public health action (7). Recommendations from these latter initiatives guided some federal agencies and epilepsy stakeholder activities in areas such as surveillance (2), but broader attention was needed.
To reinvigorate efforts to unify action in the 21st century, 24 organizations, including federal agencies in the US Department of Health and Human Services (HHS) and nonprofit organizations in Vision 20–20 (a group of epilepsy stakeholder organizations), joined together in 2010 to commission the first epilepsy report from the IOM. After receiving input through public meetings across the country and from health professional boards and associations, the IOM created a roadmap for the future. In March 2012, the IOM unveiled its seminal publication Epilepsy Across the Spectrum: Promoting Health and Understanding (2).
The report emphasized that epilepsy is a common spectrum of disorders that affects not only health but also quality of life for people of all ages; that a more coordinated approach is needed for care centering on the whole patient; that although effective treatments are available, timely referral and access to treatments fall short; and that it is an area filled with complexity and stigma. To address these and other challenges, the IOM recommended actions for a wide range of stakeholders in 7 domains (Table) (2).
For HHS, the IOM report served as a catalyst for accelerating projects under way, launching new ones, and integrating departmental efforts (2,7). In 2 years since the report was released, HHS agencies have implemented numerous recommendations, often in collaboration with community partners and also by building on initiatives in the Affordable Care Act (ACA). This article documents these HHS efforts; of the 7 domains for which the IOM recommended actions, HHS has bolstered efforts in the first 5 domains, and in the remaining two has furthered partnerships with the voluntary, nongovernmental sector (through grants, contracts, or memoranda of understanding). The Table summarizes selected HHS activities, and we provide more information by domain below.



Acknowledgments

The authors are grateful to Dr Wanjun Cui for editorial assistance in preparing the manuscript and to Captain Jose Belardo, Dr Cara Long, and Dr Story Landis for their invaluable contributions.

Author Information

Corresponding Author: Howard K. Koh, MD, MPH, Office of the Assistant Secretary for Health, US Department of Health and Human Services, 200 Independence Ave SW, Washington, DC 20201. Telephone: 202-690-7694.
Author Affiliations: Rosemarie Kobau, Vicky H. Whittemore, Marie Y. Mann, Jennifer G. Johnson, Joseph D. Hutter, Wanda K. Jones, US Department of Health and Human Services, Washington, DC.

References

  1. Neurological disorders: public health challenges. Geneva (CH): World Health Organization; 2006. http://www.who.int/mental_health/neurology/neurodiso/en/index.html. Accessed November 9, 2012.
  2. Institute of Medicine. Epilepsy across the spectrum: promoting health and understanding. Washington (DC): National Academies Press; 2012.
  3. Kobau R, Zahran H, Thurman DJ, Zack MM, Henry TR, Schachter SC, et al. Epilepsy surveillance among adults — 19 states, Behavioral Risk Factor Surveillance System, 2005. [Published erratum in: MMWR 2008;57(32):876]. MMWR Surveill Summ 2008;57(6):1–20. PubMedExternal Web Site Icon
  4. Lennox WG. Epilepsy — a problem in public health. Am J Public Health Nations Health 1951;41(5 Pt 1):533–6. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  5. US Department of Health, Education, and Welfare. Plan for nationwide action on epilepsy. Bethesda (MD): Public Health Service; 1977. 234 p.
  6. England MJ, Austin JK, Beck V, Escoffery C, Hesdorffer DC. Erasing epilepsy stigma: eight key messages. Health Promot Pract 2014;15(3):313–8.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  7. Austin JK, Carr DA, Hermann BP. Living well II: a review of progress since 2003. Epilepsy Behav 2006;9(3):386–93. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  8. NINDS common data elements: harmonizing information. Streamlining research. Bethesda (MD): National Institutes of Health, National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/research/clinical_research/toolkit/CDE_flyer_epilepsy.pdf. Accessed February 18, 2014.
  9. Centers for Disease Control and Prevention. Epilepsy in adults and access to care — United States, 2010. MMWR Morb Mortal Wkly Rep 2012;61(45):909–13. PubMedExternal Web Site Icon
  10. Centers for Disease Control and Prevention. Current trends prevalence of self-reported epilepsy — United States, 1986–1990. MMWR Morb Mortal Wkly Rep 1994;43(44):810–1, 817–8. PubMedExternal Web Site Icon
  11. Healthy People 2020. Disability and health objectives: barriers to health care. DH-6. Washington (DC): US Department of Health and Human Services; 2013. http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=9. Updated August 28, 2013. Accessed January 8, 2014.
  12. Parko K, Thurman DJ. Prevalence of epilepsy and seizures in the Navajo Nation 1998–2002. Epilepsia 2009;50(10):2180–5. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  13. Benn EK, Hauser WA, Shih T, Leary L, Bagiella E, Dayan P, et al. Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of northern Manhattan, New York City. Epilepsia 2008;49(8):1431–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  14. Selassie AW, Wilson DA, Martz GU, Smith GG, Wagner JL, Wannamaker BB. Epilepsy beyond seizure: a population-based study of comorbidities. Epilepsy Res 2014;108(2):305–15. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  15. Multiple chronic conditions: a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. Washington (DC): US Department of Health and Human Services; 2010. http://www.hhs.gov/ash/initiatives/mcc/mcc_framework.pdf. Accessed December 27, 2013.
  16. Centers for Disease Control and Prevention. Comorbidity in adults with epilepsy — United States, 2010. MMWR Morb Mortal Wkly Rep 2013;62(43):849–53. PubMedExternal Web Site Icon
  17. Kirby RS, Wingate MS, Van Naarden Braun K, Doernberg NS, Arneson CL, Benedict RE, et al. Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: a report from the Autism and Developmental Disabilities Monitoring Network. Res Dev Disabil 2011;32(2):462–9.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  18. Christensen D, Van Naarden Braun K, Doernberg NS, Maenner MJ, Arneson CL, Durkin MS, et al. Prevalence of cerebral palsy, co-occurring autism spectrum disorders, and motor functioning — Autism and Developmental Disabilities Monitoring Network, USA, 2008. Dev Med Child Neurol 2014;56(1):59–65. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  19. Fitzgerald R. Missouri ADDM EEG Lab-based Epilepsy Surveillance. Conference proceeding from the Cerebral Palsy Scientific Interest Group; 2009 Mar 17; Atlanta, GA
  20. Donner EJ. Explaining the unexplained; expecting the unexpected: where are we with sudden unexpected death in epilepsy? Epilepsy Curr 2011;11(2):45–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  21. NIH and CDC launch registry for sudden death in the young. Bethesda (MD): National Institutes of Health, National Heart, Lung, and Blood Institute; 2013. http://www.nhlbi.nih.gov/news/press-releases/2013/nih-and-cdc-launch-registry-for-sudden-death-in-the-young.html. Accessed February 18, 2014.
  22. 2014 NINDS benchmarks for epilepsy research. Bethesda (MD): National Institutes of Health, National Institute of Neurological Disorders and Stroke; 2013. http://www.ninds.nih.gov/research/epilepsyweb/2014benchmarks.htm. Accessed February 19, 2014.
  23. National Institutes of Health NeuroBioBank. Bethesda (MD): National Institutes of Health, National Institute of Mental Health; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Neurological Disorders and Stroke; 2014. https://neurobiobank.nih.gov/. Accessed February 18, 2014.
  24. The BRAIN initiative. Brain research through advancing innovative neurotechnologies (BRAIN). Bethesda (MD): National Institutes of Health; 2014. http://www.nih.gov/science/brain/. Accessed February 19, 2014.
  25. Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, et al. De novo mutations in epileptic encephalopathies. Nature 2013;501(7466):217–21. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  26. Chen J, Tsai V, Parker WE, Aronica E, Baybis M, Crino PB. Detection of human papillomavirus in human focal cortical dysplasia type IIB. Ann Neurol 2012;72(6):881–92. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  27. Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, et al. Whole-body hypothermia for neonates with hypoxic–ischemic encephalopathy. N Engl J Med 2005;353(15):1574–84. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  28. Kobau R, Price PH, Hawkins NA. News from the CDC: translating epilepsy self-management research to practice. Transl Behav Med 2012;2(2):124–5.CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  29. DiIorio C, Bamps Y, Walker ER, Escoffery C. Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav 2011;22(3):469–74. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  30. Chaytor N, Ciechanowski P, Miller JW, Fraser R, Russo J, Unutzer J, et al. Long-term outcomes from the PEARLS randomized trial for the treatment of depression in patients with epilepsy. Epilepsy Behav 2011;20(3):545–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  31. Thompson NJ, Walker ER, Obolensky N, Winning A, Barmon C, DiIorio C, et al. Distance delivery of mindfulness-based cognitive therapy for depression: Project UPLIFT. Epilepsy Behav 2010;19(3):247–54. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  32. Shegog R, Begley CE, Harding A, Dubinsky S, Goldsmith C, Hope O, et al. Description and feasibility of MINDSET: a clinic decision aid for epilepsy self-management. Epilepsy Behav 2013;29(3):527–36. CrossRefExternal Web Site Icon
  33. Morrell MJ. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology 2011;77(13):1295–304. CrossRefExternal Web Site IconPubMedExternal Web Site Icon
  34. HHS.gov/HealthCare. About the law. Washington (DC): US Department of Health and Human Services; 2010. http://www.hhs.gov/healthcare/rights/index.html. Accessed May 7, 2014.
  35. State-level estimates of gains in insurance coverage among young adults. Washington (DC): US Department of Health and Human Services; 2012. http://www.hhs.gov/healthcare/facts/factsheets/2012/06/young-adults06192012a.html. Accessed May 7, 2014.
  36. Epilepsy: improving care to children and youth with epilepsy. Washington (DC): US Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau. http://mchb.hrsa.gov/programs/epilepsy/index.html. Accessed February 18, 2014.
  37. Centers for Medicare and Medicaid Services. Medicaid and children’s health insurance programs: essential health benefits in alternative benefit plans, eligibility notices, fair hearing and appeal processes, and premiums and cost sharing; exchanges: eligibility and enrollment. Final rule. Fed Regist 2013;78(135):42159–322. PubMedExternal Web Site Icon
  38. About UCEDD. Silver Spring (MD): Association of University Centers on Disabilities. http://www.aucd.org/template/page.cfm?id=667. Accessed February 18, 2014.
  39. Austin JK, Kakacek JR, Carr D. Impact of training program on school nurses’ confidence levels in managing and supporting students with epilepsy and seizures. J Sch Nurs 2010;26(6):420–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  40. Caveness WF, Gallup GH. A survey of public attitudes toward epilepsy in 1979 with an indication of trends over the past thirty years. Epilepsia 1980;21(5):509–18. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  41. Kobau R, DiIorio CA, Anderson LA, Price PH. Further validation and reliability testing of the attitudes and beliefs about living with epilepsy (ABLE) components of the CDC epilepsy program instrument on stigma. Epilepsy Behav 2006;8(3):552–9. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  42. Sirven JI, Lopez RA, Vazquez B, Van Haverbeke P. Que es la Epilepsia? Attitudes and knowledge of epilepsy by Spanish-speaking adults in the United States. Epilepsy Behav 2005;7(2):259–65. CrossRefExternal Web Site Icon PubMedExternal Web Site Icon
  43. Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. A practical clinical definition of epilepsy. Epilepsia 2014;55(4):475–82.PubMedExternal Web Site Icon

No hay comentarios: